EVP Research & Preclinical Dev of Stoke Therapeutics Inc (30-Year Financial, Insider Trades) Gene Liau (insider trades) sold 20,000 shares of STOK on 06/01/2020 at an average price of $26.35 a share. The total sale was $527,000.
Stoke Therapeutics Inc has a market cap of $874.780 million; its shares were traded at around $26.53 .
Directors and Officers Recent Trades:
- Chief Medical Officer Barry Ticho sold 1,365 shares of STOK stock on 06/01/2020 at the average price of $27.39. The price of the stock has decreased by 3.14% since.
- EVP Research & Preclinical Dev Gene Liau sold 20,000 shares of STOK stock on 06/01/2020 at the average price of $26.35. The price of the stock has increased by 0.68% since.
- COO & CBO Huw M. Nash sold 2,107 shares of STOK stock on 06/01/2020 at the average price of $27.18. The price of the stock has decreased by 2.39% since.
- EVP Research & Preclinical Dev Gene Liau sold 7,500 shares of STOK stock on 05/22/2020 at the average price of $30. The price of the stock has decreased by 11.57% since.
For the complete insider trading history of STOK, click here
.